「s1」の検索結果
166件：81～85件目を表示
-
ラニビズマブBS硝子体内注射用キット10mg/mL「センジュ」
ブ後続 1 ］ Ranibizumab （Genetical Recombination） [Ranibizumab Biosimilar 1]〔JAN〕 分子式：C2158H3282N562O681S12 分子量：48,379.29 本 質：ラニビズマブ ［ラニビズマブ後続 1 ］ （以下、ラニビズ マブ後続 1 ） は、 遺伝子組換えヒト化モノクローナル 抗体のFab断片であり、マウス抗ヒト血...
https://www.senju.co.jp/system/files/product_other_file/2024-08/ranibizumab-bs_202408_C5.pdf -
General Announcement: November 1, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. S
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101_0.pdf -
General Announcement: November 1, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. S
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101.pdf -
临床试验信息 | 研究与开发 | 千寿制药株式会社
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
http://www.senju.co.jp/chinese/rd/trial.html -
Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical
From eye drops to contact lens preparations-Mytear eye solutions head a diverse line of trusted products Building on a reputation for excellence in ophthalmological drugs, Senju Pharmaceutical has cul
https://www.senju.co.jp/english/about/business/otc.html